Predictive Value of Preablation Stimulated Thyroglobulin and Thyroglobulin/Thyroid-Stimulating Hormone Ratio in Differentiated Thyroid Cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference24 articles.
1. Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors.;Mihailovic;Cancer Biother Radiopharm,2007
2. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer.;Mazzaferri;J Clin Endocrinol Metab,2001
3. . Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.;Hay;World J Surg,2002
4. . Cause of death in patients with well-differentiated thyroid carcinoma.;Beasley;Laryngoscope,2001
5. . Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.;Cooper;Thyroid,2006
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Radioactive iodine therapy for follicular thyroid cancer: a 15 years follow-up study of Chinese patients;Nuclear Medicine Communications;2023-12-14
2. A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate‑ and high‑risk differentiated thyroid cancer patients: a bi-center retrospective study;Endocrine;2023-12-12
3. Surgical outcomes of endoscopic thyroidectomy approaches for thyroid cancer: a systematic review and network meta-analysis;Frontiers in Endocrinology;2023-12-04
4. A Novel Nomogram Integrated with Preablation Stimulated Thyroglobulin and Thyroglobulin/Thyroid-Stimulating Hormone Ratio to Predict the Therapeutic Response of Intermediate‑ and High‑Risk Differentiated Thyroid Cancer Patients: a Bi-center Retrospective Study;2023-09-08
5. Establishing a Cutoff Serum Thyroglobulin Value for the Diagnosis and Management of Well-Differentiated Thyroid Cancer;World Journal of Nuclear Medicine;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3